Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China.

Qu CX, Kamangar F, Fan JH, Yu B, Sun XD, Taylor PR, Chen BE, Abnet CC, Qiao YL, Mark SD, Dawsey SM. Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. J Natl Cancer Inst. 2007 Aug 15; 99(16):1240-7.

View in: PubMed

subject areas

Adult
Antibodies, Neoplasm
Chemoprevention
China
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Incidence
Liver Neoplasms
Male
Middle Aged
Minerals
Vitamins

authors with profiles

Farin Kamangar

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support